Sign in

NCT07751003Not yet recruiting

Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support

A Randomized Controlled Trial of Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

This study is a randomized controlled trial designed to compare the effectiveness of active remote intervention versus passive monitoring alone in patients with Chronic Obstructive Pulmonary Disease (COPD) and chronic hypercapnic respiratory failure who are receiving home non-invasive respiratory support. The primary goal is to evaluate the impact on health-related quality of life and the frequency of acute exacerbations over a 12-month period.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
236 (estimated)
First submitted
30 Jul 2026
Start date
1 Aug 2027
Primary completion date
31 Dec 2027
Lead sponsor
Sir Run Run Shaw Hospital
Diseases
COPD
NCT number
NCT07751003

What you commit to

  • Study type: Interventional
  • Planned participants: 236
  • From 1 Aug 2027 to the primary completion date, 31 Dec 2027
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent severe pulmonary diseases (e.g., active tuberculosis, diffuse pulmonary fibrosis, advanced lung cancer).

Other illness

  • Chronic respiratory failure primarily caused by non-COPD conditions (e.g., neuromuscular disease, chest wall deformity, or severe obesity hypoventilation syndrome).
  • Severe cognitive impairment or psychiatric illness that would prevent cooperation with remote management.
  • Other severe systemic diseases with an expected survival of less than 1 year (e.g., advanced malignancy).

Other

  • Pregnant or lactating women.

Who the study is looking for

  • Meets the diagnostic criteria for Chronic Obstructive Pulmonary Disease (COPD) with confirmed persistent airflow limitation by spirometry.
  • Hospitalized due to an acute exacerbation of COPD.
  • Stable daytime arterial blood gas analysis showing PaCO₂ ≥ 50 mmHg, with hypoxemia.
  • Already receiving or planned to receive long-term home non-invasive respiratory support.
  • Capable of using a smartphone or tablet for video communication and has internet access.
  • Willing to participate and provides written informed consent.

Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Second Xiangya Hospital of Central South University
Coordinator of this site? Confirm its status
ChangshaChinaUnknown status
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Taizhou Hospital of Integrated Traditional Chinese and Western Medicine
Coordinator of this site? Confirm its status
WenlingChinaUnknown status
Henan Provincial People's Hospital
Coordinator of this site? Confirm its status
ZhengzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.